Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Oct;30(5):315-36.
doi: 10.1023/b:jopa.0000008157.26321.3c.

A two-part mixture model for longitudinal adverse event severity data

Affiliations
Comparative Study

A two-part mixture model for longitudinal adverse event severity data

Kenneth G Kowalski et al. J Pharmacokinet Pharmacodyn. 2003 Oct.

Abstract

We fit a mixed effects logistic regression model to longitudinal adverse event (AE) severity data (four-point ordered categorical response) to describe the dose-AE severity response for an investigational drug. The distribution of the predicted interindividual random effects (Bayes predictions) was extremely bimodal. This extreme bimodality indicated that biased parameter estimates and poor predictive performance were likely. The distribution's primary mode was composed of patients that did not experience an AE. Moreover, the Bayes predictions of these non-AE patients were nearly degenerative, i.e., the predictions were nearly identical. To resolve this extreme bimodality we propose using a two-part mixture modeling approach. The first part models the incidence of AE's, and the second part models the severity grade given the patient had an AE. Unconditional probability predictions are calculated by mixing the incidence and severity model probability predictions. We also report results of simulation studies, which assess the predictive and statistical (bias and precision) performance of our approach.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):67-88 - PubMed
    1. Biometrics. 2001 Mar;57(1):43-52 - PubMed
    1. Clin Pharmacol Ther. 1994 Sep;56(3):309-22 - PubMed
    1. Biometrics. 1982 Dec;38(4):1041-6 - PubMed
    1. Clin Pharmacol Ther. 1996 Dec;60(6):619-35 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources